Timeline

2017
(Q3) Complete hotel outpatient clinical study (estimated)
(Q3) Complete CRC clinical study (estimated)
(Q2) Start NIH funded artificial pancreas CRC clinical study (estimated)
(Q2) CRC study IDE approved by FDA
2016
(Q4) Investigational device complete. IDE Pre-submission
(Q3) Finalize protocol for NIH funded outpatient hotel clinical studies
2015
Dose Safety Controller software product available in February
2014
Awarded NIH Grant - Use of Dose Safety Controller APS in Subjects with Hypoglycemic Unawareness
2013
US patent No. 8548544 issued for “System, Method & Article for Controlling the Dispensing of Insulin”
2012
Dose Safety Inc. formed and registered in WA State
2011
Awarded NIH Grant - Advanced Hypoglycemia Prevention Capabilities in Fuzzy Logic APS
2011
Completed JDRF-funded clinical study at Benaroya Research Institute in Seattle
2010
Awarded JDRF innovative research grant
2009
US Patent filed
2008
Begin collaboration with Sansum Diabetes Institute and UCSB
2007
Development of Dose Safety prototype Control System V 0.11
2006
First of three provisional patent submissions
2005
Completed Proof of Principal clinical trial
2004
Development of Dose Safety prototype Control System V 0.1
2003
Founding of Dose Safety Company as WA State partnership
2002
Idea of use of fuzzy logic for insulin pump control